Audible. Prime Member exclusive offer. First 3 months free, $14.95 a month after 3 months. Cancel anytime. Offer ends July 31, 2024, 11:59 PM PT. Get this deal

Optimizing the Identification of HER2-Low Breast Cancer
Jul 30 2024
Length: 24 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Optimizing the Identification of HER2-Low Breast Cancer

Listen for free

View show details

Summary
Dr Kimberly H Allison from the Stanford Cancer Institute in Stanford, California discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayTestingHER2LowBC24).

Show more Show less

Physical Illness & Disease Hygiene & Healthy Living Science

Show more Show less

What listeners say about Optimizing the Identification of HER2-Low Breast Cancer

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon